A CLEAR CHOICE FOR TOLERABILITY AND CONVENIENCE
- Just 1 dose can provide 24-hour allergy symptom relief1
- Both doctors and patients agree that ease of use and once-daily dosing can enhance treatment adherence2
Loratadine, the active ingredient in Claritin®, provides non-drowsy allergy symptom relief3
- Significantly less sedation during the workday compared with cetirizine
*P<0.01; †P =0.02; ‡P =0.04; §P =0.01.
Adapted from Salmun et al, 2000.
A randomized, double-blind, parallel-group study involving 60 patients (≥12 years) with active allergic rhinitis.
qd=once daily.
Loratadine, the active ingredient in Claritin®, has no significant effect on driving ability4
- In a clinical study, Claritin® had no significant effect on weaving motion or deviation of speed4
- Claritin® has no significant effects on psychometric performance4
- Additional studies have confirmed that Claritin® has no significant effect on driving ability or psychometric performance5-7
Claritin® is acceptable for pilot use by the FAA.8
Adapted from Ramaekers et al, 1992.
A 6-way, double-blind, cross-over trial involving 16 healthy subjects (22 to 35 years).
SEM=standard error of the mean.
Claritin® has different label warnings than competitors1,9-11
*Based on selected attributes of US OTC Drug Facts labels—when used as directed.
Claritin® is considered safe and well tolerated* with an adverse event profile similar to placebo12
Rates of adverse events reported for Claritin® in placebo-controlled AR clinical trials were similar to placebo.
*When used as directed.
AEs occurring with a frequency of >2% in placebo-controlled AR clinical trials in patients aged 12 years and older.
AEs=adverse events; AR=allergic rhinitis.
CLARITIN® SAMPLES & COUPONS
Claritin® offers allergy relief for kids and adults in a variety of forms and flavors.
Help your patients tackle their tough allergy symptoms with samples and coupons for Claritin® products.
References: 1. Claritin® Drug Facts. NDA019658. 2. Ciprandi G. Clinical utility and patient adherence with ebastine for allergic rhinitis. Patient Prefer Adherence. 2010;4:389-395. 3. Salmun LM, Gates D, Scharf M, et al. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. Clin Ther. 2000;22(5):573-582. 4. Ramaekers JG, Uiterwijk MMC, O’Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42(4):363-369. 5. Verster JC, Volkerts ER. Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol. 2004;92(3):294-303. doi:10.1016/S1081-1206(10)61566-9 6. Popescu F-D. H1 antihistamines and driving. J Med Life. 2008;1(3):262-268. 7. Kay GG, Harris AG. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy. 1999;29 Suppl 3:147-150. doi:10.1046/j.1365-2222.1999.0290s3147.x 8. Federal Aviation Administration. What over-the-counter (OTC) medications can I take and still be safe to fly? Accessed August 4, 2021. https://www.faa.gov/licenses_certificates/medical_certification/media/OTCMedicationsforPilots.pdf 9. Zyrtec® Drug Facts. NDC 50580-726-36. 10. Allegra® Allergy Drug Facts. 11. Xyzal® Drug Facts. Accessed December 14, 2021. https://www.xyzal.com/hcp/download/DrugFactsLabel.pdf 12. Claritin®. Prescribing Information. Schering Corporation; 2000.
